740 Y-P
Based on 260 publication(s) in Google Scholar
740 Y-P (740YPDGFR; PDGFR 740Y-P) is a potent and cell-permeable PI3K activator. 740 Y-P readily binds GST fusion proteins containing both the N- and C- terminal SH2 domains of p85 but fails to bind GST alone.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.64%
- CAS 番号: 1236188-16-1
- 分子式: C141H222N43O39PS3
- 分子量:3270.70
-
保管条件:
Sealed storage, away from moisture and light.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
MedChemExpress(MCE)の使用を引用している文献 740 Y-P
More- Mol Cancer. 2022 May 10;21(1):112. [Abstract]
- Drug Resist Updat. 2024 Dec 3:78:101179. [Abstract]
- Mol Cell. 2025 Mar 19:S1097-2765(25)00186-8. [Abstract]
- Nat Commun. 2024 Sep 12;15(1):7996. [Abstract]
- Adv Sci (Weinh). 2026 Jan 21:e19191. [Abstract]
- Adv Sci (Weinh). 2025 Apr;12(13):e2410032. [Abstract]
- J Clin Invest. 2023 Jan 17;133(2):e153470. [Abstract]
- Theranostics. 2024 Jul 8;14(11):4278-4296. [Abstract]
- Exp Mol Med. 2023 May;55(5):939-951. [Abstract]
- Biomaterials. 2019 Feb;194:57-72. [Abstract]
- J Exp Clin Cancer Res. 2021 Aug 12;40(1):255. [Abstract]
- J Exp Clin Cancer Res. 2020 Jun 30;39(1):123. [Abstract]
- Carbon. 2023 Jan 25, 217, 118617.
- J Control Release. 2025 Oct 22;388(Pt 2):114350. [Abstract]
- Genome Med. 2025 Sep 25;17(1):102. [Abstract]
- Mater Today Bio. 2022 Jul 1;16:100344. [Abstract]
- Int J Biol Sci. 2025 Aug 11;21(12):5206-5222. [Abstract]
- J Colloid Interface Sci. 2025 Oct 8;703(Pt 2):139206. [Abstract]
- Cell Death Dis. 2025 Jun 16;16(1):451. [Abstract]
- Cell Death Dis. 2021 Sep 13;12(9):845. [Abstract]
- Acta Biomater. 2018 Nov:81:278-292. [Abstract]
- Genes Dis. 2021 Jul 1;9(6):1650-1661. [Abstract]
- Proc Natl Acad Sci U S A. 2026 Jul 7;123(27):e2523789123.
- Cell Commun Signal. 2020 Aug 24;18(1):131. [Abstract]
- Int J Biol Macromol. 2025 Jan 10:139766. [Abstract]
- Int J Biol Macromol. 2024 Sep 10:135547. [Abstract]
- Int J Biol Macromol. 2023 Jul 31:244:125373. [Abstract]
- Phytomedicine. 2026 Jul:156:158218. [Abstract]
- Phytomedicine. 2026 Apr:153:158000. [Abstract]
- Phytomedicine. 2025 May:140:156498. [Abstract]
- Phytomedicine. 2023 Dec:121:155117. [Abstract]
- Phytomedicine. 2023 Jul 25:116:154873. [Abstract]
- BMC Med. 2022 Dec 8;20(1):475. [Abstract]
- Phytomedicine. 2022 Oct:105:154360. [Abstract]
- Phytomedicine. 2022 May:99:154014. [Abstract]
- Free Radic Biol Med. 2023 Oct 10;209(Pt 1):55-69. [Abstract]
- Apoptosis. 2025 Feb;30(1-2):16-34. [Abstract]
- Apoptosis. 2024 Aug;29(7-8):1185-1197. [Abstract]
- J Headache Pain. 2022 Aug 10;23(1):98. [Abstract]
- J Transl Med. 2024 Nov 29;22(1):1085. [Abstract]
- Biomed Pharmacother. 2024 Nov:180:117560. [Abstract]
- J Transl Med. 2023 Nov 16;21(1):817. [Abstract]
- J Transl Med. 2021 Feb 10;19(1):62. [Abstract]
- Arch Pharm Res. 2021 Feb;44(2):194-204. [Abstract]
- Biomed Pharmacother. 2020 Nov;131:110689. [Abstract]
- PLoS Biol. 2026 Jan 22;24(1):e3003581. [Abstract]
- Cell Rep. 2021 Nov 16;37(7):110007. [Abstract]
- Mol Med. 2023 Oct 3;29(1):133. [Abstract]
- Phytother Res. 2024 Jul;38(7):3509-3524. [Abstract]
- Phytother Res. 2023 Aug;37(8):3572-3582. [Abstract]
- J Agric Food Chem. 2025 May 2. [Abstract]
- Cell Mol Life Sci. 2024 Mar 13;81(1):133. [Abstract]
- J Agric Food Chem. 2022 Dec 21;70(50):15804-15817. [Abstract]
- Cell Biosci. 2019 Aug 27;9:68. [Abstract]
- Ecotoxicol Environ Saf. 2026 Mar 15:313:119962. [Abstract]
- Biomater Adv. 2026 Mar:180:214576. [Abstract]
- Cell Biol Toxicol. 2025 Jul 1;41(1):110. [Abstract]
- Int J Mol Med. 2025 Nov;56(5):194. [Abstract]
- Int J Mol Med. 2023 May;51(5):40. [Abstract]
- Int J Mol Med. 2021 May;47(5):67. [Abstract]
- Int J Mol Med. 2021 Feb;47(2):688-698. [Abstract]
- J Invest Dermatol. 2026 Jan 23:S0022-202X(26)00030-8. [Abstract]
- Chin Med. 2022 Sep 29;17(1):115. [Abstract]
- Biochem Pharmacol. 2025 Dec;242(Pt 3):117405. [Abstract]
- Biochem Pharmacol. 2024 Nov 9:116620. [Abstract]
- Cell Prolif. 2022 Sep 26;e13342. [Abstract]
- Mol Cell Proteomics. 2023 Sep;22(9):100628. [Abstract]
- World J Gastroenterol. 2026 Mar 28;32(12).
- J Ethnopharmacol. 2025 Jan 18:119381. [Abstract]
- J Ethnopharmacol. 2025 Jan 30;337(Pt 2):118910. [Abstract]
- J Ethnopharmacol. 2024 May 10:325:117768. [Abstract]
- J Ethnopharmacol. 2024 Mar 25:322:117628. [Abstract]
- J Ethnopharmacol. 2021 Dec 5:281:114438. [Abstract]
- Inflammopharmacology. 2023 Feb;31(1):369-384. [Abstract]
- Cells. 2023 Jan 3;12(1):194. [Abstract]
- Drug Des Devel Ther. 2026 Jan 27:20:561725. [Abstract]
- Drug Des Devel Ther. 2026 Jan 27;20:1-16.
- Bioresour Bioprocess. 2025 Jul 30;12(1):82. [Abstract]
- Bone Joint Res. 2025 Feb 6;14(2):97-110. [Abstract]
- Glia. 2023 Mar;71(3):720-741. [Abstract]
- Life Sci. 2021 Nov 1:284:119107. [Abstract]
- Life Sci. 2019 Sep 15:233:116696. [Abstract]
- Int J Mol Sci. 2024 Dec 25;26(1):84. [Abstract]
- J Nutr Biochem. 2024 Jul 16:109702. [Abstract]
- Int J Mol Sci. 2023 May 19;24(10):9000. [Abstract]
- J Nutr Biochem. 2022 Feb:100:108882. [Abstract]
- Int J Oncol. 2021 Jul;59(1):42. [Abstract]
- Int J Oncol. 2021 May;58(5):23. [Abstract]
- Ann N Y Acad Sci. 2025 Nov 24. [Abstract]
- Pharmaceuticals (Basel). 2025 Sep 16;18(9):1378. [Abstract]
- Pharm Biol. 2022 Dec;60(1):75-86. [Abstract]
- Front Pharmacol. 2021 Jul 15:12:667644. [Abstract]
- Front Pharmacol. 2020 Feb 25;11:114. [Abstract]
- Eur J Pharmacol. 2026 May 28:1025:178925. [Abstract]
- Int Immunopharmacol. 2026 Mar 15:173:116306. [Abstract]
- Bioorg Chem. 2025 Dec 18:169:109400. [Abstract]
- Bioorg Chem. 2025 Sep 16:165:109002. [Abstract]
- Int Immunopharmacol. 2025 Aug 3:163:115304. [Abstract]
- Int Immunopharmacol. 2025 Apr 4:151:114352. [Abstract]
- Noncoding RNA Res. 2024 Nov 12:11:38-47. [Abstract]
- Eur J Pharmacol. 2024 Sep 10:176991. [Abstract]
- Eur J Pharmacol. 2024 Sep 10:176824. [Abstract]
- Int Immunopharmacol. 2024 Jul 26:139:112717. [Abstract]
- Int Immunopharmacol. 2024 May 17:134:112241. [Abstract]
- Int Immunopharmacol. 2024 May 30:133:112005. [Abstract]
- Eur J Pharmacol. 2024 Apr 5:968:176401. [Abstract]
- Int Immunopharmacol. 2023 Sep 5;124(Pt A):110876. [Abstract]
- Eur J Pharmacol. 2023 Sep 5:954:175863. [Abstract]
- Int Immunopharmacol. 2023 Sep:122:110579. [Abstract]
- Neuropharmacology. 2025 Nov 15:279:110631. [Abstract]
- Gene Ther. 2024 Nov;31(11-12):594-606. [Abstract]
- Cancers (Basel). 2025 Aug 29;17(17):2846. [Abstract]
- Cancers (Basel). 2023 Mar 28;15(7):2023. [Abstract]
- J Dairy Sci. 2022 Apr;105(4):3405-3415. [Abstract]
- Comp Biochem Physiol C Toxicol Pharmacol. 2026 Jun 4:110596. [Abstract]
- Mol Neurobiol. 2025 Mar;62(3):3615-3629. [Abstract]
- ACS Omega. 2022 Nov 16;7(47):42723-42732. [Abstract]
- Mediators Inflamm. 2026;2026(1):e3260549. [Abstract]
- Stem Cell Rev Rep. 2026 Jan 30;22(3):1325-1340.
- J Cell Mol Med. 2024 Jul;28(13):e18386. [Abstract]
- Drug Dev Res. 2022 Nov;83(7):1673-1682. [Abstract]
- Bioengineered. 2022 Apr;13(4):10047-10060. [Abstract]
- Drug Dev Res. 2022 Aug;83(5):1152-1166. [Abstract]
- Bioengineered. 2021 Dec;12(2):12940-12953. [Abstract]
- J Inflamm Res. 2026 Apr 17:19:592917. [Abstract]
- J Inflamm Res. 2025 Aug 3:18:10389-10402. [Abstract]
- iScience. 2024 Jan 17;27(2):108926. [Abstract]
- J Integr Med. 2025 Sep 4:S2095-4964(25)00137-2. [Abstract]
- J Cell Physiol. 2024 Jun;239(6):e31259. [Abstract]
- J Funct Foods. 2023 Oct, 109, 105770.
- Sci Rep. 2026 Jun 26.
- Sci Rep. 2025 May 9;15(1):16205. [Abstract]
- Sci Rep. 2025 Apr 19;15(1):13539. [Abstract]
- Sci Rep. 2025 Mar 20;15(1):9644. [Abstract]
- Sci Rep. 2025 Mar 4;15(1):7639. [Abstract]
- Sci Rep. 2024 Aug 30;14(1):20231. [Abstract]
- Sci Rep. 2024 Sep 5;14(1):20802. [Abstract]
- Sci Rep. 2023 Jul 21;13(1):11795. [Abstract]
- Oncol Rep. 2022 Oct;48(4):169. [Abstract]
- Fish Shellfish Immunol. 2022 Jan:120:648-657. [Abstract]
- Aging (Albany NY). 2021 Sep 27;13(18):22502-22515. [Abstract]
- Sci Rep. 2021 Sep 29;11(1):19268. [Abstract]
- Oncol Rep. 2021 May;45(5):63. [Abstract]
- Oncol Rep. 2020 Mar;43(3):919-929. [Abstract]
- Cell Signal. 2026 Sep:145:112570. [Abstract]
- Cell Signal. 2026 Sep:145:112616. [Abstract]
- Cell Signal. 2025 Dec 18:139:112336. [Abstract]
- Cell Signal. 2025 Nov:135:111984. [Abstract]
- Cell Signal. 2025 Nov:135:112026. [Abstract]
- Mol Cell Biochem. 2022 Jul;477(7):1947-1957. [Abstract]
- Mol Cell Biochem. 2022 May;477(5):1541-1553. [Abstract]
- Cytokine. 2022 Feb:150:155776. [Abstract]
- Cell Signal. 2020 Jul;71:109606. [Abstract]
- Heliyon. 2024 Aug 20;10(17):e36579. [Abstract]
- Heliyon. 2024 Jul 10;10(14):e34397. [Abstract]
- Heliyon. 2024 Jun 10;10(12):e32802. [Abstract]
- Heliyon. 2024 May 31;10(11):e32230. [Abstract]
- Exp Cell Res. 2026 Apr 1;457(1):114924. [Abstract]
- Mol Med Rep. 2026 Feb;33(2):60. [Abstract]
- Food Chem Toxicol. 2025 Oct:204:115664. [Abstract]
- Viruses. 2023 Jul 28;15(8):1646. [Abstract]
- Mol Med Rep. 2021 Jan;23(1):76. [Abstract]
- Exp Cell Res. 2019 Dec 15;385(2):111691. [Abstract]
- Toxicol Appl Pharmacol. 2026 Jun 26:514:117928.
- Eur J Med Res. 2025 Dec 30;31(1):170. [Abstract]
- J Gastroenterol Hepatol. 2025 Aug;40(8):1991-2006. [Abstract]
- BMC Complement Med Ther. 2023 Aug 22;23(1):295. [Abstract]
- BMC Cancer. 2023 Jul 5;23(1):628. [Abstract]
- BMC Cancer. 2022 Jun 18;22(1):671. [Abstract]
- Toxicol Appl Pharmacol. 2022 Apr 15:441:115971. [Abstract]
- J Hepatocell Carcinoma. 2021 Nov 3;8:1323-1338. [Abstract]
- Toxicol Appl Pharmacol. 2020 Dec 15;409:115335. [Abstract]
- Appl Biochem Biotechnol. 2026 Apr 28. [Abstract]
- Appl Biochem Biotechnol. 2026 Mar 13. [Abstract]
- Epigenetics. 2023 Dec;18(1):2239607. [Abstract]
- Pathol Res Pract. 2023 Sep:249:154717. [Abstract]
- J Pharm Pharmacol. 2022 Sep 1;74(9):1251-1260. [Abstract]
- Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun;399(9):14421-14437. [Abstract]
- Hum Cell. 2026 Apr 7;39(4):61. [Abstract]
- Funct Integr Genomics. 2026 Jan 27;26(1):32. [Abstract]
- Kaohsiung J Med Sci. 2025 Nov 5:e70131. [Abstract]
- Front Biosci (Landmark Ed). 2024 Aug 19;29(8):289. [Abstract]
- Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb;397(2):1003-1013. [Abstract]
- Cancer Med. 2023 Mar;12(5):5781-5797. [Abstract]
- OncoTargets and Therapy Dovepress. 2019 Oct 16;12:8537-8552. [Abstract]
- J Bioenerg Biomembr. 2026 Feb 12;58(1):2. [Abstract]
- Mol Immunol. 2025 Dec 18:189:181-191. [Abstract]
- Mol Immunol. 2025 Sep:185:27-38. [Abstract]
- Biol Reprod. 2023 Nov 15;109(5):736-748. [Abstract]
- Arch Biochem Biophys. 2023 Jul 15:743:109645. [Abstract]
- Genomics. 2023 Jul;115(4):110636. [Abstract]
- IBRO Neurosci Rep. 2026 Jan 21:20:186-195. [Abstract]
- Discov Oncol. 2025 Sep 30;16(1):1789. [Abstract]
- Oral Dis. 2024 Oct;30(7):4231-4242. [Abstract]
- J Clin Lab Anal. 2022 Dec;36(12):e24720. [Abstract]
- Neurogastroenterol Motil. 2020 Oct;32(10):1514-1528. [Abstract]
- Int J Biochem Cell Biol. 2026 May:194:106928. [Abstract]
- J Biochem Mol Toxicol. 2025 Apr;39(4):e70210. [Abstract]
- Genes (Basel). 2023 Apr 20;14(4):944. [Abstract]
- Mol Biol Rep. 2023 Jan;50(1):687-696. [Abstract]
- Technol Cancer Res Treat. 2020 Jan-Dec:19:1533033820957023. [Abstract]
- Onco Targets Ther. 2019 Dec 4;12:10639-10650. [Abstract]
- Immun Inflamm Dis. 2026 Apr;14(4):e70429. [Abstract]
- Exp Eye Res. 2023 Jan:226:109335. [Abstract]
- Toxicol In Vitro. 2022 Apr;80:105328. [Abstract]
- Curr Microbiol. 2025 Feb 3;82(3):110. [Abstract]
- PLoS One. 2024 Sep 27;19(9):e0311143. [Abstract]
- PLoS One. 2024 Oct 16;19(10):e0311419. [Abstract]
- Theriogenology. 2026 Aug:260:117909. [Abstract]
- Electron J Biotechnol. 2025 Aug 13.
- J Steroid Biochem Mol Biol. 2025 Jul 3:254:106825. [Abstract]
- Cell Biochem Biophys. 2025 Jun;83(2):2023-2033. [Abstract]
- Cell Biochem Biophys. 2025 Jun;83(2):1785-1798. [Abstract]
- World J Gastrointest Oncol. 2023 Oct 15;15(10):1739-1755. [Abstract]
- Exp Ther Med. 2021 Sep;22(3):1017. [Abstract]
- Biochem Biophys Res Commun. 2025 Sep 8:778:152337. [Abstract]
- Biochem Biophys Res Commun. 2025 May 16:771:152037. [Abstract]
- Biochem Biophys Res Commun. 2024 Jul 23:718:149983. [Abstract]
- Oncol Lett. 2023 Nov 15;27(1):17. [Abstract]
- J Mol Histol. 2023 Dec;54(6):621-631. [Abstract]
- Biochem Biophys Res Commun. 2023 Sep 3:671:246-254. [Abstract]
- Oncol Lett. 2023 Apr 13;25(6):224. [Abstract]
- Korean J Physiol Pharmacol. 2022 Nov 1;26(6):541-556. [Abstract]
- Biochem Biophys Res Commun. 2022 May 21;605:162-170. [Abstract]
- Oncol Lett. 2021 Dec;22(6):812. [Abstract]
- Mol Genet Genomics. 2026 Jun 16;301(1):138. [Abstract]
- Eur J Histochem. 2025 Jun 17;69(3). [Abstract]
- Arch Dermatol Res. 2024 Dec 5;317(1):70. [Abstract]
- Int J Gen Med. 2025 Sep 19:18:5699-5716. [Abstract]
- Curr Eye Res. 2025 Jun 24:1-9. [Abstract]
- Cancer Rep (Hoboken). 2025 May;8(5):e70220. [Abstract]
- Clin Med Insights Oncol. 2021 May 5:15:11795549211012666. [Abstract]
- Cytotechnology. 2026 Jun;78(3):96. [Abstract]
- Cytotechnology. 2025 Apr;77(2):77. [Abstract]
- In Vitro Cell Dev Biol Anim. 2022 Jun;58(6):491-502. [Abstract]
- Lett Drug Des Discov. 2026 Jan 16.
- Folia Neuropathol. 2025;63(3):269-281. [Abstract]
- Am J Transl Res. 2025 Mar 15;17(3):2145-2153. [Abstract]
- Ir J Med Sci. 2023 Apr;192(2):561-567. [Abstract]
- Am J Transl Res. 2021 Apr 15;13(4):2060-2076. [Abstract]
- Respir Physiol Neurobiol. 2020 Oct;281:103496. [Abstract]
- Curr Med Sci. 2025 Oct 16. [Abstract]
- Curr Med Sci. 2025 Apr;45(2):253-263. [Abstract]
- Braz J Med Biol Res. 2025 Mar 24:58:e14408. [Abstract]
- Braz J Med Biol Res. 2024 Aug 19:57:e13796. [Abstract]
- Tradit Med Res. 2020 May.
- bioRxiv. 2026 Apr 1:2026.03.31.715684. [Abstract]
- bioRxiv. 2026 Mar 29:2026.03.27.714536. [Abstract]
- SSRN. 2025 Dec 12.
- SSRN. 2025 Sep 19.
- bioRxiv. 2025 Mar 26:2025.03.24.645017. [Abstract]
- Research Square Preprint. 2024 May 2.
- Research Square Preprint. 2024 Mar 25.
- Research Square Preprint. 2023 Aug 10.
- Research Square Preprint. 2023 Apr 13.
- bioRxiv. 2023 Mar 25:2023.03.23.534007. [Abstract]
- Contrast Media Mol Imaging. 2022 Jul 14:2022:2109908. [Abstract]
- Research Square Print. 2022 May.
- Dis Markers. 2021 Sep 1:2021:9950663. [Abstract]
- Oxid Med Cell Longev. 2021 Mar 30:2021:6661534. [Abstract]
-
WB
-
WB
-
WB
-
WB
-
WB
生物活性
|
PI3K |
740 Y-P (50 μg/mL; 48 hours) specificly stimulates mitogenesis in medium is better than EGF or FGF at stimulating entry into S-phase, it shows the percentage of cells in S-phase for 48.3% in C2 cells. Additionally, LY294002 (HY-10108) or Wortmannin (HY-10197) potently inhibits the mitogenic response stimulated by the peptide[1].740 Y-P (1 μg/mL) stimulates mitogenesis at the lowest concentration tested. The peptide stimulates mitogenesis in both the presence and absence of serum (0.5%), and in the former instance a maximal response observed at 50 μg/mL. 740Y-P to stimulate mitogenesis is highly specific and not a general feature of a cell permeable SH2 domain binding peptides[1].740 Y-P (30 μM; 24 hours) remarkably inhibits the level of LC3-II/LC3-I in GO-induced PC12 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:PC12 cells
-
Concentration:30 μM
-
Incubation Time:24 hours
-
Result:Inhibited the protein expression of LC3-II.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 1236188-16-1
-
性状 Solid
-
分子量 3270.70
-
分子式 C141H222N43O39PS3
-
Color White to off-white
-
別名
740YPDGFR; PDGFR 740Y-P
-
配列
Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-Ser-Asp-Gly-Gly-{Tyr(PO2)}-Met-Asp-Met-Ser
-
シーケンスの短縮
RQIKIWFQNRRMKWKKSDGG-{Tyr(PO2)}-MDMS
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Sealed storage, away from moisture and light
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications (260)
-
Journal Impact Factor
-
Most Recent
-
Mol Cancer
Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer. [Abstract]2022 May 10;21(1):112. PMID: 35538494 -
Drug Resist Updat
CEA-induced PI3K/AKT pathway activation through the binding of CEA to KRT1 contributes to oxaliplatin resistance in gastric cancer. [Abstract]2024 Dec 3:78:101179. PMID: 39644827 -
Mol Cell
PI3Kβ functions as a protein kinase to promote cellular protein O-GlcNAcylation and acetyl-CoA production for tumor growth. [Abstract]2025 Mar 19:S1097-2765(25)00186-8. PMID: 40132583 -
Nat Commun
Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions. [Abstract]2024 Sep 12;15(1):7996. PMID: 39266508 -
Adv Sci (Weinh)
Macrophage-Derived Ferritin Exacerbates Silica-Induced Pulmonary Fibrosis via PIK3R2-Mediated Fibroblast Differentiation. [Abstract]2026 Jan 21:e19191. PMID: 41566645 -
Adv Sci (Weinh)
Intestinal Gastrin/CCKBR Axis Protects against Type 2 Diabetes by Reducing Intestinal Glucose Absorption through the PI3K/Akt/eIF4B Signaling Pathway. [Abstract]2025 Apr;12(13):e2410032. PMID: 39950948
740 Y-P purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Apr;12(13):e2410032. [Abstract]
Protein expression and quantification of SGLT1, GLUT2, p-PI3K, p-AKT, p-S6K1, and p-eIF4B were performed. GAPDH was used to normalize the data. 740Y-P (30 μM; 24 h) was an activator of the PI3K/Akt signaling pathway.
-
J Clin Invest
Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47. [Abstract]2023 Jan 17;133(2):e153470. PMID: 36413402 -
Theranostics
Stimulation by exosomes from hypoxia-preconditioned hair follicle mesenchymal stem cells facilitates mitophagy by inhibiting the PI3K/AKT/mTOR signaling pathway to alleviate ulcerative colitis. [Abstract]2024 Jul 8;14(11):4278-4296. PMID: 39113800
740 Y-P purchased from MedChemExpress. Usage Cited in: Theranostics. 2024 Jul 8;14(11):4278-4296. [Abstract]
Western blotting was used to measure p-PI3K/PI3K, p-AKT/AKT, and p-mTOR/mTOR expression in MODE-K cells incubated with 740 Y-P (25 μg/mL; 24 h).
-
Exp Mol Med
Mesenchymal stem cell-derived extracellular vesicles protect against abdominal aortic aneurysm formation by inhibiting NET-induced ferroptosis. [Abstract]2023 May;55(5):939-951. PMID: 37121969
740 Y-P purchased from MedChemExpress. Usage Cited in: Exp Mol Med. 2023 May;55(5):939-951. [Abstract]
Western blot showing PI3K, AKT, p-AKT, GPX4, ACSL4, TFR1, and SLC7A11 in the tissue samples of ApoE−/− mice infused with saline or Ang II, with or without 740 Y-P (10 mg/kg/d) treatment. n = 3 in each group.
-
Biomaterials
Mussel-inspired injectable hydrogel and its counterpart for actuating proliferation and neuronal differentiation of retinal progenitor cells. [Abstract]2019 Feb;194:57-72. PMID: 30583149 -
J Exp Clin Cancer Res
XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor. [Abstract]2021 Aug 12;40(1):255. PMID: 34384466 -
J Exp Clin Cancer Res
BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer. [Abstract]2020 Jun 30;39(1):123. PMID: 32605589
740 Y-P purchased from MedChemExpress. Usage Cited in: J Exp Clin Cancer Res. 2020 Jun 30;39(1):123. [Abstract]
Protein expression levels of p-AktSer473, p-mTORSer2448 with or without 740Y-P treatment are measured by Western blotting. Pretreatment with 740Y-P (PI3K agonist) inhibits downregulation of p-AktSer473 and p-mTORSer2448 expression induced by overexpression of BDH2.
-
-
J Control Release
Inflammation-targeted nanoparticles modulate macrophage polarization for coronary therapy in Kawasaki disease. [Abstract]2025 Oct 22;388(Pt 2):114350. PMID: 41135700 -
Genome Med
2025 Sep 25;17(1):102. PMID: 40999499 -
Mater Today Bio
Carbon dots enhance extracellular matrix secretion for dentin-pulp complex regeneration through PI3K/Akt/mTOR pathway-mediated activation of autophagy. [Abstract]2022 Jul 1;16:100344. PMID: 35833197 -
Int J Biol Sci
ANXA6 Overexpression Causes Abnormal Decidual Macrophage-Trophoblast Crosstalk in Recurrent Spontaneous Abortion. [Abstract]2025 Aug 11;21(12):5206-5222. PMID: 40959268 -
J Colloid Interface Sci
Engineering a cancer organoid-based platform for the early preclinical evaluation of the antitumor efficacy and safety of hydrophilic 2D metallic MoS2 nanosheets. [Abstract]2025 Oct 8;703(Pt 2):139206. PMID: 41082801 -
Cell Death Dis
SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1+ myeloid cells in hepatocellular carcinoma. [Abstract]2025 Jun 16;16(1):451. PMID: 40523887 -
Cell Death Dis
LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma. [Abstract]2021 Sep 13;12(9):845. PMID: 34518524 -
Acta Biomater
Graphene oxide induces p62/SQSTM-dependent apoptosis through the impairment of autophagic flux and lysosomal dysfunction in PC12 cells. [Abstract]2018 Nov:81:278-292. PMID: 30273743
740 Y-P purchased from MedChemExpress. Usage Cited in: Acta Biomater. 2018 Nov:81:278-292. [Abstract]
PC12 cells are pretreated with 740-YP (30 μM), or SC79 (13.7 μM), or 3BDO (100 μM) for 1 h, and for the duration of GO (50 μg/mL) incubation for 24 h. LC3 turnover is detected by western blotting.
-
Genes Dis
PGRN exacerbates the progression of non-small cell lung cancer via PI3K/AKT/Bcl-2 antiapoptotic signaling. [Abstract]2021 Jul 1;9(6):1650-1661. PMID: 36157487 -
-
Cell Commun Signal
Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma. [Abstract]2020 Aug 24;18(1):131. PMID: 32831114 -
Int J Biol Macromol
Sibanin, a novel black fly-derived Kunitz protease inhibitor, prevents thrombus formation in mice by anticoagulation-antiplatelet duality. [Abstract]2025 Jan 10:139766. PMID: 39800030 -
Int J Biol Macromol
Polysaccharides from Ostrea rivularis alleviate type II diabetes induced-retinopathy and VGEF165-induced angiogenesis via PI3K/AKT signaling pathway. [Abstract]2024 Sep 10:135547. PMID: 39265902 -
Int J Biol Macromol
Polysaccharide from Strongylocentrotus nudus eggs regulates intestinal epithelial autophagy through CD36/PI3K-Akt pathway to ameliorate inflammatory bowel disease. [Abstract]2023 Jul 31:244:125373. PMID: 37327932 -
Phytomedicine
Narciclasine alleviates zearalenone-induced focal adhesion damage and anoikis in rat Sertoli cells through PI3K signaling pathway. [Abstract]2026 Jul:156:158218. PMID: 42025009 -
Phytomedicine
Platycodin D alleviates idiopathic pulmonary fibrosis by targeting PPP2R1A and regulating the PP2A-mediated PI3K/Akt pathway to inhibit fibroblast transdifferentiation. [Abstract]2026 Apr:153:158000. PMID: 41759424 -
Phytomedicine
Artesunate attenuates skin hypertrophic scar formation by inhibiting fibroblast activation and EndMT of vascular endothelial cells. [Abstract]2025 May:140:156498. PMID: 40055124 -
Phytomedicine
Isovitexin alleviates hepatic fibrosis by regulating miR-21-mediated PI3K/Akt signaling and glutathione metabolic pathway: based on transcriptomics and metabolomics. [Abstract]2023 Dec:121:155117. PMID: 37820467 -
Phytomedicine
2023 Jul 25:116:154873. PMID: 37257328 -
BMC Med
A novel 450-nm laser-mediated sinoporphyrin sodium-based photodynamic therapy induces autophagic cell death in gastric cancer through regulation of the ROS/PI3K/Akt/mTOR signaling pathway. [Abstract]2022 Dec 8;20(1):475. PMID: 36482460 -
Phytomedicine
A discovery of clinically approved Panlongqi Tablet for repositioning to treat osteoarthritis by inhibiting PI3K/AKT activation. [Abstract]2022 Oct:105:154360. PMID: 35964457 -
Phytomedicine
Biosynthesis and cytotoxic effect of silymarin-functionalized selenium nanoparticles induced autophagy mediated cellular apoptosis via downregulation of PI3K/Akt/mTOR pathway in gastric cancer. [Abstract]2022 May:99:154014. PMID: 35247670 -
Free Radic Biol Med
FKBP5 regulates trophoblast-macrophage crosstalk in recurrent spontaneous abortion through PI3K/AKT and NF-κB signaling pathways. [Abstract]2023 Oct 10;209(Pt 1):55-69. PMID: 37827456 -
Apoptosis
PRELP inhibits colorectal cancer progression by suppressing epithelial-mesenchymal transition and angiogenesis via the inactivation of the FGF1/PI3K/AKT pathway. [Abstract]2025 Feb;30(1-2):16-34. PMID: 39242474 -
Apoptosis
TBC1D10B promotes tumor progression in colon cancer via PAK4‑mediated promotion of the PI3K/AKT/mTOR pathway. [Abstract]2024 Aug;29(7-8):1185-1197. PMID: 38824479 -
J Headache Pain
Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine. [Abstract]2022 Aug 10;23(1):98. PMID: 35948867 -
J Transl Med
Cholesterol overload in macrophages drives metabolic dysfunction-associated steatohepatitis via inhibiting 7-dehydrocholesterol reductase in mice. [Abstract]2024 Nov 29;22(1):1085. PMID: 39614331 -
Biomed Pharmacother
Fraxinellone protects against cardiac injury and decreases ventricular fibrillation susceptibility during myocardial ischemia-reperfusion. [Abstract]2024 Nov:180:117560. PMID: 39442236 -
J Transl Med
HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma. [Abstract]2023 Nov 16;21(1):817. PMID: 37974228 -
J Transl Med
Rosuvastatin exerts anti-atherosclerotic effects by improving macrophage-related foam cell formation and polarization conversion via mediating autophagic activities. [Abstract]2021 Feb 10;19(1):62. PMID: 33568202 -
Arch Pharm Res
Chemerin reverses the malignant phenotype and induces differentiation of human hepatoma SMMC7721 cells. [Abstract]2021 Feb;44(2):194-204. PMID: 33502677 -
Biomed Pharmacother
Fetuin B overexpression suppresses proliferation, migration, and invasion in prostate cancer by inhibiting the PI3K/AKT signaling pathway. [Abstract]2020 Nov;131:110689. PMID: 32892030 -
PLoS Biol
Optineurin binding to the novel interacting partner Junction plakoglobin prevents muscle atrophy in mice. [Abstract]2026 Jan 22;24(1):e3003581. PMID: 41570057 -
Cell Rep
CNOT6/6L-mediated mRNA degradation in ovarian granulosa cells is a key mechanism of gonadotropin-triggered follicle development. [Abstract]2021 Nov 16;37(7):110007. PMID: 34788619 -
Mol Med
RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway. [Abstract]2023 Oct 3;29(1):133. PMID: 37789274 -
Phytother Res
Scutellarein alleviates osteoarthritis progression through the PI3K/Akt/NF-kappaB signaling pathway: In vitro and in vivo studies. [Abstract]2024 Jul;38(7):3509-3524. PMID: 38695125 -
Phytother Res
Silibinin attenuated pseudo-allergic reactions and mast cell degranulation via PLCγ and PI3K/Akt signaling pathway. [Abstract]2023 Aug;37(8):3572-3582. PMID: 37115717 -
J Agric Food Chem
Mechanistic Insights into Maltol-Mediated Reversal of Postmenopausal Osteoporosis via Regulation of CDK14 Ubiquitination in Macrophages. [Abstract]2025 May 2. PMID: 40315161 -
Cell Mol Life Sci
PEBP4 deficiency aggravates LPS-induced acute lung injury and alveolar fluid clearance impairment via modulating PI3K/AKT signaling pathway. [Abstract]2024 Mar 13;81(1):133. PMID: 38472560 -
J Agric Food Chem
Ginsenoside Rk1 Prevents UVB Irradiation-Mediated Oxidative Stress, Inflammatory Response, and Collagen Degradation via the PI3K/AKT/NF-κB Pathway In Vitro and In Vivo. [Abstract]2022 Dec 21;70(50):15804-15817. PMID: 36472249 -
Cell Biosci
Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE-/- mice. [Abstract]2019 Aug 27;9:68. PMID: 31467666 -
Ecotoxicol Environ Saf
Glyphosate promotes calcium oxalate crystal-induced renal injury by modulating the PI3K/Akt-mediated mechanism. [Abstract]2026 Mar 15:313:119962. PMID: 41797104 -
Biomater Adv
Novel Ce/Cu-modified black ceramics disrupted mitochondrial dysfunction and tricarboxylic acid cycle to induce cuproptosis in osteosarcoma cells. [Abstract]2026 Mar:180:214576. PMID: 41218466 -
Cell Biol Toxicol
TEAD4-mediated upregulation of LPAR3 augments hepatic stellate cell activation in portal hypertension. [Abstract]2025 Jul 1;41(1):110. PMID: 40591004 -
Int J Mol Med
Effects of sesamin on the chemosensitivity, invasiveness and immune evasion mechanism of human lung adenocarcinoma. [Abstract]2025 Nov;56(5):194. PMID: 40937589 -
Int J Mol Med
Dihydroartemisinin inhibits the activation and proliferation of hepatic stellate cells by regulating miR‑29b‑3p. [Abstract]2023 May;51(5):40. PMID: 37026504 -
Int J Mol Med
Rosmarinic acid inhibits cell proliferation, migration, and invasion and induces apoptosis in human glioma cells. [Abstract]2021 May;47(5):67. PMID: 33649774 -
Int J Mol Med
ADAM10 promotes the proliferation of ligamentum flavum cells by activating the PI3K/AKT pathway. [Abstract]2021 Feb;47(2):688-698. PMID: 33416124 -
J Invest Dermatol
Botulinum neurotoxin type A1 alleviates bleomycin-induced skin fibrosis by inhibiting phosphatidylinositol 3-kinase-protein kinase B (PI3K-Akt) pathway and associated cell cycle and proliferation. [Abstract]2026 Jan 23:S0022-202X(26)00030-8. PMID: 41581589 -
Chin Med
Nitidine chloride induces caspase 3/GSDME-dependent pyroptosis by inhibting PI3K/Akt pathway in lung cancer. [Abstract]2022 Sep 29;17(1):115. PMID: 36175965 -
Biochem Pharmacol
ACOD1/Itaconate regulates trophoblast function through the PI3K/Akt/FOLR1 axis to participate in the pathogenesis of recurrent spontaneous abortion. [Abstract]2025 Dec;242(Pt 3):117405. PMID: 41047036 -
Biochem Pharmacol
PX-478 induces apoptosis in acute myeloid leukemia under hypoxia by inhibiting the PI3K/AKT/mTOR pathway through downregulation of GBE1. [Abstract]2024 Nov 9:116620. PMID: 39528073 -
Cell Prolif
2022 Sep 26;e13342. PMID: 36162830 -
Mol Cell Proteomics
The Hyperproliferation Mechanism of Cholesteatoma Based on Proteomics: SNCA Promotes Autophagy-Mediated Cell Proliferation through the PI3K/AKT/CyclinD1 Signaling Pathway. [Abstract]2023 Sep;22(9):100628. PMID: 37532176 -
-
J Ethnopharmacol
Danggui niantong decoction attenuates synovial fibrosis through regulating PI3k/AKT signaling pathway. [Abstract]2025 Jan 18:119381. PMID: 39832630 -
J Ethnopharmacol
Bie Jia Jian pill ameliorates BDL-induced cholestatic hepatic fibrosis in rats by regulating intestinal microbial composition and TMAO-mediated PI3K/AKT signaling pathway. [Abstract]2025 Jan 30;337(Pt 2):118910. PMID: 39369915 -
J Ethnopharmacol
An ethanolic extract of Arctium lappa L. leaves ameliorates experimental atherosclerosis by modulating lipid metabolism and inflammatory responses through PI3K/Akt and NF-κB singnaling pathways. [Abstract]2024 May 10:325:117768. PMID: 38253275 -
J Ethnopharmacol
Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson's disease rats. [Abstract]2024 Mar 25:322:117628. PMID: 38158101 -
J Ethnopharmacol
Compound Danshen Dripping Pill ameliorates post ischemic myocardial inflammation through synergistically regulating MAPK, PI3K/AKT and PPAR signaling pathways. [Abstract]2021 Dec 5:281:114438. PMID: 34390798 -
Inflammopharmacology
Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3 inflammasome-mediated pyroptosis. [Abstract]2023 Feb;31(1):369-384. PMID: 36401729 -
Cells
Synergism of Feeding and Digestion Regulated by the Neuropeptide F System in Ostrinia furnacalis Larvae. [Abstract]2023 Jan 3;12(1):194. PMID: 36611986 -
Drug Des Devel Ther
Paroxetine as a Therapeutic Agent in Inflammatory Osteolysis: Mechanistic Insights and Efficacy. [Abstract]2026 Jan 27:20:561725. PMID: 41868178 -
-
Bioresour Bioprocess
Unveiling the common mechanisms and therapeutic targets of medicinal herbs in acute pancreatitis: a network pharmacology and experimental validation approach. [Abstract]2025 Jul 30;12(1):82. PMID: 40736877 -
Bone Joint Res
Melatonin alleviates senile osteoporosis by regulating autophagy and enhancing fracture healing in aged mice. [Abstract]2025 Feb 6;14(2):97-110. PMID: 39912870 -
Glia
EphA4/ephrinA3 reverse signaling mediated downregulation of glutamate transporter GLAST in Müller cells in an experimental glaucoma model. [Abstract]2023 Mar;71(3):720-741. PMID: 36416239 -
Life Sci
H3K9ac modification was involved in doxorubicin induced apoptosis by regulating Pik3ca transcription in H9C2 cells. [Abstract]2021 Nov 1:284:119107. PMID: 33508292 -
Life Sci
Knockdown of LSD1 meliorates Ox-LDL-stimulated NLRP3 activation and inflammation by promoting autophagy via SESN2-mesiated PI3K/Akt/mTOR signaling pathway. [Abstract]2019 Sep 15:233:116696. PMID: 31351969 -
Int J Mol Sci
Non-Structural Protein V of Canine Distemper Virus Induces Autophagy via PI3K/AKT/mTOR Pathway to Facilitate Viral Replication. [Abstract]2024 Dec 25;26(1):84. PMID: 39795943 -
J Nutr Biochem
Protective effect of folic acid on MNNG-induced proliferation of esophageal epithelial cells via the PI3K/AKT/mTOR signaling pathway. [Abstract]2024 Jul 16:109702. PMID: 39025456 -
Int J Mol Sci
Analgesic Effects of Fisetin, Peimine, Astaxanthin, Artemisinin, Bardoxolone Methyl and 740 Y-P and Their Influence on Opioid Analgesia in a Mouse Model of Neuropathic Pain. [Abstract]2023 May 19;24(10):9000. PMID: 37240346 -
J Nutr Biochem
Lipophagy mediated glucose-induced changes of lipid deposition and metabolism via ROS dependent AKT-Beclin1 activation. [Abstract]2022 Feb:100:108882. PMID: 34655756 -
Int J Oncol
The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway. [Abstract]2021 Jul;59(1):42. PMID: 34013357 -
Int J Oncol
Oncogenic role of abnormal spindle‑like microcephaly‑associated protein in lung adenocarcinoma. [Abstract]2021 May;58(5):23. PMID: 33786609 -
Ann N Y Acad Sci
COMMD4 Drives Skin Cutaneous Melanoma Progression by Targeting PI3K-p85 to Activate PI3K-AKT. [Abstract]2025 Nov 24. PMID: 41283898 -
Pharmaceuticals (Basel)
Puerarin Inhibits Proliferation, Migration and Invasion of Colon Cancer Cells and Induces Apoptosis via Suppression of the PI3K/AKT Signaling Pathway. [Abstract]2025 Sep 16;18(9):1378. PMID: 41011246 -
Pharm Biol
Deciphering the molecular mechanism of tetrandrine in inhibiting hepatocellular carcinoma and increasing sorafenib sensitivity by combining network pharmacology and experimental evaluation. [Abstract]2022 Dec;60(1):75-86. PMID: 34962429 -
Front Pharmacol
Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling. [Abstract]2021 Jul 15:12:667644. PMID: 34335245 -
Front Pharmacol
Eriodictyol Inhibits Proliferation, Metastasis and Induces Apoptosis of Glioma Cells via PI3K/Akt/NF-κB Signaling Pathway. [Abstract]2020 Feb 25;11:114. PMID: 32158391 -
Eur J Pharmacol
Phloretin inhibits osteoclast differentiation and alleviates disuse osteoporosis through the PI3K/AKT/NF-κB pathway. [Abstract]2026 May 28:1025:178925. PMID: 42081991 -
Int Immunopharmacol
Methamphetamine regulates microglial polarization and glycolytic activity to promote Parkinson's disease through the LIPH/LPA/PI3K/AKT signaling axis. [Abstract]2026 Mar 15:173:116306. PMID: 41628513 -
Bioorg Chem
Elucidation of the anti-NSCLC mechanism of flavonoid derivative JW4 by an integrative approach of network pharmacology and experimental verification. [Abstract]2025 Dec 18:169:109400. PMID: 41447948 -
Bioorg Chem
Exploring the mechanism of Levistolide A in the treatment of lung cancer cells based on network analysis, molecular docking and experimental validation. [Abstract]2025 Sep 16:165:109002. PMID: 40974659 -
Int Immunopharmacol
Hesperidin ameliorates hepatocyte cell cycle disruption, apoptosis, and necroptosis in mice with nonalcoholic fatty liver disease via the VEGFA-PI3K/AKT pathway. [Abstract]2025 Aug 3:163:115304. PMID: 40759079 -
Int Immunopharmacol
Garcinol promotes wound healing in diabetic mice by regulating inflammation and NLRP3 inflammasome-mediated pyroptosis via the PI3K/Akt/NF-κB pathway. [Abstract]2025 Apr 4:151:114352. PMID: 40022821 -
Noncoding RNA Res
Targeting NUCKS1 with a fragment of tRNAAsn(GUU) of Chinese yew for the treatment of colorectal cancer. [Abstract]2024 Nov 12:11:38-47. PMID: 39736854 -
Eur J Pharmacol
ENAH transcriptionally activated by YY1 promotes growth and invasion of laryngocarcinoma cells through PI3K/AKT signaling. [Abstract]2024 Sep 10:176991. PMID: 39265883 -
Eur J Pharmacol
Restoration of ARA metabolic disorders in vascular smooth muscle cells alleviates intimal hyperplasia. [Abstract]2024 Sep 10:176824. PMID: 39265882 -
Int Immunopharmacol
Isorhapontigenin delays senescence and matrix degradation of nucleus pulposus cells via PI3K/AKT/mTOR-mediated autophagy pathway in vitro and alleviates intervertebral disc degeneration in vivo. [Abstract]2024 Jul 26:139:112717. PMID: 39067404 -
Int Immunopharmacol
Moringin alleviates DSS-induced ulcerative colitis in mice by regulating Nrf2/NF-κB pathway and PI3K/AKT/mTOR pathway. [Abstract]2024 May 17:134:112241. PMID: 38761782 -
Int Immunopharmacol
Chondroprotective effects of Apolipoprotein D in knee osteoarthritis mice through the PI3K/AKT/mTOR signaling pathway. [Abstract]2024 May 30:133:112005. PMID: 38626543 -
Eur J Pharmacol
Tenacissoside H repressed the progression of glioblastoma by inhibiting the PI3K/Akt/mTOR signaling pathway. [Abstract]2024 Apr 5:968:176401. PMID: 38331340 -
Int Immunopharmacol
Germacrone mitigates cardiac remodeling by regulating PI3K/AKT-mediated oxidative stress, inflammation, and apoptosis. [Abstract]2023 Sep 5;124(Pt A):110876. PMID: 37683399 -
Eur J Pharmacol
1,8-Cineole ameliorates endothelial injury and hypertension induced by L-NAME through regulation of autophagy via PI3K/mTOR signaling pathway. [Abstract]2023 Sep 5:954:175863. PMID: 37380045 -
Int Immunopharmacol
Saikosaponin d modulates the polarization of tumor-associated macrophages by deactivating the PI3K/AKT/mTOR pathway in murine models of pancreatic cancer. [Abstract]2023 Sep:122:110579. PMID: 37433245 -
Neuropharmacology
The glutaminase inhibitor JHU-083 mitigates cognitive dysfunction in a mouse model of post-traumatic stress disorder. [Abstract]2025 Nov 15:279:110631. PMID: 40812515 -
Gene Ther
BRD9 promotes the progression of gallbladder cancer via CST1 upregulation and interaction with FOXP1 through the PI3K/AKT pathway and represents a therapeutic target. [Abstract]2024 Nov;31(11-12):594-606. PMID: 39306629 -
Cancers (Basel)
ITGA2 Mediates the Resistance of Hepatocellular Carcinoma to Lenvatinib by Activating the AKT/FOXO3A Signaling Pathway. [Abstract]2025 Aug 29;17(17):2846. PMID: 40940943 -
Cancers (Basel)
BI-D1870 Induces Mitotic Dysfunction and Apoptosis in Neuroblastoma by Regulating the PI3K-Akt-mTORC1 Signal Axis. [Abstract]2023 Mar 28;15(7):2023. PMID: 37046682 -
J Dairy Sci
β-Hydroxybutyrate impairs the release of bovine neutrophil extracellular traps through inhibiting phosphoinositide 3-kinase-mediated nicotinamide adenine dinucleotide phosphate oxidase reactive oxygen species production. [Abstract]2022 Apr;105(4):3405-3415. PMID: 35123783 -
Comp Biochem Physiol C Toxicol Pharmacol
Rosuvastatin calcium and pravastatin sodium regulate the antioxidant system in zebrafish liver through the PI3K/Nrf2/ARE signaling pathway. [Abstract]2026 Jun 4:110596. PMID: 42248540 -
Mol Neurobiol
TRPV4 Blockage Inhibits the Neurogenesis in the Adult Hippocampal Dentate Gyrus Following Pilocarpine‑Induced Status Epilepticus. [Abstract]2025 Mar;62(3):3615-3629. PMID: 39312069 -
ACS Omega
Silymarin-Functionalized Selenium Nanoparticles Prevent LPS-Induced Inflammatory Response in RAW264.7 Cells through Downregulation of the PI3K/Akt/NF-κB Pathway. [Abstract]2022 Nov 16;7(47):42723-42732. PMID: 36467957 -
Mediators Inflamm
FGFR2 is a Candidate Immune-Associated Marker of Diabetic Foot Ulcer That Promotes Keratinocyte Function by Activating the PI3K/Akt and MAPK Pathways. [Abstract]2026;2026(1):e3260549. PMID: 41983566 -
-
J Cell Mol Med
Plumbagin ameliorates LPS-induced acute lung injury by regulating PI3K/AKT/mTOR and Keap1-Nrf2/HO-1 signalling pathways. [Abstract]2024 Jul;28(13):e18386. PMID: 38990057 -
Drug Dev Res
The cytotoxicity of karanjin toward breast cancer cells is involved in the PI3K/Akt signaling pathway. [Abstract]2022 Nov;83(7):1673-1682. PMID: 36065628 -
Bioengineered
Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3'-kinase/protein kinase B/mammalian target of rapamycin pathway. [Abstract]2022 Apr;13(4):10047-10060. PMID: 35412944 -
Drug Dev Res
Secoisolariciresinol diglucoside induces pyroptosis by activating caspase-1 to cleave GSDMD in colorectal cancer cells. [Abstract]2022 Aug;83(5):1152-1166. PMID: 35472101 -
Bioengineered
Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation. [Abstract]2021 Dec;12(2):12940-12953. PMID: 34847838 -
J Inflamm Res
Acupuncture Activates PI3K/Akt Pathway to Promote Spinal Microglial M2 Polarization and Alleviate Spastic Hemiplegia Following Ischemic Stroke. [Abstract]2026 Apr 17:19:592917. PMID: 42022268 -
J Inflamm Res
Long Non-Coding RNA lncTAF15:1-1 Promotes CCL5 Secretion and Cell Migration of Monocyte-Derived Dendritic Cells via PI3K/AKT/mTOR Pathway in Systemic Lupus Erythematosus. [Abstract]2025 Aug 3:18:10389-10402. PMID: 40787263 -
iScience
Ibrutinib-induced pulmonary angiotensin-converting enzyme activation promotes atrial fibrillation in rats. [Abstract]2024 Jan 17;27(2):108926. PMID: 38357670 -
J Integr Med
Astragaloside IV delayed the epithelial-mesenchymal transition in peritoneal fibrosis by inhibiting the activation of EGFR and PI3K-AKT pathways. [Abstract]2025 Sep 4:S2095-4964(25)00137-2. PMID: 40975639 -
J Cell Physiol
ZNF263 cooperates with ZNF31 to promote the drug resistance and EMT of pancreatic cancer through transactivating RNF126. [Abstract]2024 Jun;239(6):e31259. PMID: 38515383 -
-
-
Sci Rep
SHP1 and its downstream p38/SP1/PI3K/YAP/Notch-1 signaling in trophoblast cells suppressed the progression of Preeclampsia via inhibiting proliferation of SMCs. [Abstract]2025 May 9;15(1):16205. PMID: 40346122 -
Sci Rep
ITGA5 induces mesenchymal transformation to promote gliomas progression via PI3K/AKT/mTORC1 signaling pathway. [Abstract]2025 Apr 19;15(1):13539. PMID: 40253517 -
Sci Rep
Low intensity pulsed ultrasound alleviates synovial fibrosis in osteoarthritis via the PI3K/AKT pathway. [Abstract]2025 Mar 20;15(1):9644. PMID: 40113833 -
Sci Rep
miR-21 regulates autophagy and apoptosis of ectopic endometrial stromal cells of adenomyosis via PI3K/ AKT/ mTOR pathway. [Abstract]2025 Mar 4;15(1):7639. PMID: 40038429 -
Sci Rep
Genipin promotes the apoptosis and autophagy of neuroblastoma cells by suppressing the PI3K/AKT/mTOR pathway. [Abstract]2024 Aug 30;14(1):20231. PMID: 39215133 -
Sci Rep
Mechanism of apoptosis in oral squamous cell carcinoma promoted by cardamonin through PI3K/AKT signaling pathway. [Abstract]2024 Sep 5;14(1):20802. PMID: 39242879 -
Sci Rep
NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling. [Abstract]2023 Jul 21;13(1):11795. PMID: 37479837 -
Oncol Rep
Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer. [Abstract]2022 Oct;48(4):169. PMID: 35920185 -
Fish Shellfish Immunol
PI3K/AKT/p53 pathway inhibits infectious spleen and kidney necrosis virus infection by regulating autophagy and immune responses. [Abstract]2022 Jan:120:648-657. PMID: 34968710 -
Aging (Albany NY)
Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells. [Abstract]2021 Sep 27;13(18):22502-22515. PMID: 34580235 -
Sci Rep
Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway. [Abstract]2021 Sep 29;11(1):19268. PMID: 34588580 -
Oncol Rep
TMEM100 induces cell death in non‑small cell lung cancer via the activation of autophagy and apoptosis. [Abstract]2021 May;45(5):63. PMID: 34184748 -
Oncol Rep
Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K/Akt signaling pathway. [Abstract]2020 Mar;43(3):919-929. PMID: 32020231 -
Cell Signal
CLDN6 inhibits breast cancer growth by inducing autophagic cell death through SOX4 m6A modification. [Abstract]2026 Sep:145:112570. PMID: 42070760 -
Cell Signal
ADAR1-mediated destabilization of INPP5J mRNA promotes PI3K/AKT/mTOR signal to inhibit autophagy in lung adenocarcinoma. [Abstract]2026 Sep:145:112616. PMID: 42173180 -
Cell Signal
ANXA1 regulates microglia polarization and autophagy via PI3K/Akt/mTOR pathway to reduce inflammatory injury after cerebral ischemia-reperfusion. [Abstract]2025 Dec 18:139:112336. PMID: 41421718 -
Cell Signal
GCN2 promotes fatty acid metabolism through the activation of PI3K/AKT signaling in gastric cancer. [Abstract]2025 Nov:135:111984. PMID: 40651685 -
Cell Signal
Bavachinin alleviates allergic rhinitis by modulating gut microbiota and inhibiting NLRP3-mediated epithelial pyroptosis through PI3K/AKT/NF-κB signaling pathway. [Abstract]2025 Nov:135:112026. PMID: 40738272 -
Mol Cell Biochem
Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer. [Abstract]2022 Jul;477(7):1947-1957. PMID: 35362843 -
Mol Cell Biochem
2022 May;477(5):1541-1553. PMID: 35184257 -
Cytokine
Inhibition of macrophage migration inhibitory factor alleviates LPS-induced inflammation response of HEI-OC1 cells via suppressing NF-κB signaling. [Abstract]2022 Feb:150:155776. PMID: 34864396 -
Cell Signal
Upregulation of HSP72 attenuates tendon adhesion by regulating fibroblast proliferation and collagen production via blockade of the STAT3 signaling pathway. [Abstract]2020 Jul;71:109606. PMID: 32199935 -
Heliyon
Mechanisms of Yiai Fuzheng formula in the treatment of triple-negative breast cancer based on UPLC-Q-Orbitrap-HRMS, network pharmacology, and experimental validation. [Abstract]2024 Aug 20;10(17):e36579. PMID: 39319146 -
Heliyon
2024 Jul 10;10(14):e34397. PMID: 39104494 -
Heliyon
Investigating the potential role of α-SNAP in preventing chemotherapy-induced ovarian dysfunction: Insights from cellular and animal models. [Abstract]2024 Jun 10;10(12):e32802. PMID: 38994045 -
Heliyon
Identification of octyl gallate, a novel apoptosis-inducing compound for colon cancer therapy, from Sanguisorba officinalis L. by cell membrane chromatography and UHPLC-(Q)TOF-MS/MS. [Abstract]2024 May 31;10(11):e32230. PMID: 38933948 -
Exp Cell Res
ADAM8 negatively regulates the osteogenic differentiation of rat tendon stem cells through inhibiting the PI3K/AKT signaling pathway. [Abstract]2026 Apr 1;457(1):114924. PMID: 41655939 -
Mol Med Rep
ABCC9 knockdown attenuates isoproterenol‑induced myocardial hypertrophy by inhibiting the PI3K/AKT signaling pathway. [Abstract]2026 Feb;33(2):60. PMID: 41347799 -
Food Chem Toxicol
CDDO-Me triggers ROS-dependent ferroptosis and apoptosis in cervical cancer via targeting PI3K/Nrf2 pathway. [Abstract]2025 Oct:204:115664. PMID: 40714179 -
Viruses
Host DNA Demethylation Induced by DNMT1 Inhibition Up-Regulates Antiviral OASL Protein during Influenza a Virus Infection. [Abstract]2023 Jul 28;15(8):1646. PMID: 37631988 -
Mol Med Rep
lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway. [Abstract]2021 Jan;23(1):76. PMID: 33236153 -
Exp Cell Res
Rafoxanide promotes apoptosis and autophagy of gastric cancer cells by suppressing PI3K /Akt/mTOR pathway. [Abstract]2019 Dec 15;385(2):111691. PMID: 31678170 -
-
Eur J Med Res
DACT1 inhibits cuproptosis and promotes cell malignancy via activation of PI3K/AKT signaling in laryngeal squamous cell carcinoma. [Abstract]2025 Dec 30;31(1):170. PMID: 41469752 -
J Gastroenterol Hepatol
Sanguisorba officinalis L. and Sophora japonica L. Inhibit Angiogenesis in Ulcerative Colitis. [Abstract]2025 Aug;40(8):1991-2006. PMID: 40518692 -
BMC Complement Med Ther
2023 Aug 22;23(1):295. PMID: 37608281 -
BMC Cancer
GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K/AKT pathway. [Abstract]2023 Jul 5;23(1):628. PMID: 37407932 -
BMC Cancer
Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and β-catenin. [Abstract]2022 Jun 18;22(1):671. PMID: 35715752 -
Toxicol Appl Pharmacol
2022 Apr 15:441:115971. PMID: 35276125 -
J Hepatocell Carcinoma
CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis. [Abstract]2021 Nov 3;8:1323-1338. PMID: 34765572 -
Toxicol Appl Pharmacol
2,5-Hexanedione influences primordial follicular development in cultured neonatal mouse ovaries by interfering with the PI3K signaling pathway via miR-214-3p. [Abstract]2020 Dec 15;409:115335. PMID: 33197454 -
Appl Biochem Biotechnol
Brucea Javanica Oil Attenuates Osteosarcoma Progression by Reprogramming Tumor-associated Macrophages via Inhibiting PI3K/AKT Pathway. [Abstract]2026 Apr 28. PMID: 42047961 -
Appl Biochem Biotechnol
RNF8 Relieves asthma-induced DNA Damage and Ferroptosis in Airway Epithelial Cells Through the AKT-NRF2 Axis. [Abstract]2026 Mar 13. PMID: 41824268 -
Epigenetics
Oncogenic DNA methyltransferase 1 activates the PI3K/AKT/mTOR signalling by blocking the binding of HSPB8 and BAG3 in melanoma. [Abstract]2023 Dec;18(1):2239607. PMID: 37523636 -
Pathol Res Pract
Clinical importance and PI3K/Akt pathway-dependent anti-proliferative role of PALMD and DPT in breast cancer. [Abstract]2023 Sep:249:154717. PMID: 37556876 -
J Pharm Pharmacol
Eleutheroside E functions as anti-cervical cancer drug by inhibiting the phosphatidylinositol 3-kinase pathway and reprogramming the metabolic responses. [Abstract]2022 Sep 1;74(9):1251-1260. PMID: 35789274 -
Naunyn Schmiedebergs Arch Pharmacol
β-defensin-3 promoted osteosarcoma progression via activating the PI3K/AKT pathway and regulated tumor immune response. [Abstract]2026 Jun;399(9):14421-14437. PMID: 41984190 -
Hum Cell
AKR1B10 drives hepatic steatosis and inflammation in metabolic dysfunction-associated steatotic liver disease via PI3K/AKT-mediated autophagy suppression. [Abstract]2026 Apr 7;39(4):61. PMID: 41945278 -
Funct Integr Genomics
GCSH promotes colorectal cancer progression by inhibiting Cuproptosis through the PI3K/AKT-FDX1 axis. [Abstract]2026 Jan 27;26(1):32. PMID: 41591502 -
Kaohsiung J Med Sci
Melatonin Exerts Chondroprotective Effects Against Osteoarthritis by Promoting PI3K/AKT/FoxO3-Mediated Mitophagy. [Abstract]2025 Nov 5:e70131. PMID: 41190713 -
Front Biosci (Landmark Ed)
Splicing Factor PTBP1 Silencing Induces Apoptosis of Human Cervical Cancer Cells via PI3K/AKT Pathway and Autophagy. [Abstract]2024 Aug 19;29(8):289. PMID: 39206910 -
Naunyn Schmiedebergs Arch Pharmacol
Gentiopicroside inhibits retinoblastoma cell proliferation, invasion, and tumorigenesis in nude mice by suppressing the PI3K/AKT pathway. [Abstract]2024 Feb;397(2):1003-1013. PMID: 37555853 -
Cancer Med
Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway. [Abstract]2023 Mar;12(5):5781-5797. PMID: 36336972 -
OncoTargets and Therapy Dovepress
2019 Oct 16;12:8537-8552. PMID: 31802891 -
J Bioenerg Biomembr
Shionone attenuates endoplasmic reticulum stress-associated ferroptosis in cardiomyocytes by reducing LCN2 and regulating PI3K/Akt signaling. [Abstract]2026 Feb 12;58(1):2. PMID: 41678102 -
Mol Immunol
Isoimperatorin inhibits cell proliferation and induces apoptosis via regulating PI3K/AKT pathway in acute lymphoblastic leukemia. [Abstract]2025 Dec 18:189:181-191. PMID: 41418420 -
Mol Immunol
GDF15 activates the PI3K/AKT pathway to mediate macrophage M2 polarization to promote prostate cancer resistance to docetaxel. [Abstract]2025 Sep:185:27-38. PMID: 40674958 -
Biol Reprod
AQP9 causes recurrent spontaneous abortion by inhibiting trophoblast cell EMT and invasion through the PI3K/AKT pathway. [Abstract]2023 Nov 15;109(5):736-748. PMID: 37602667 -
Arch Biochem Biophys
Activation of Sestrin2 accelerates deep second-degree burn wound healing through PI3K/AKT pathway. [Abstract]2023 Jul 15:743:109645. PMID: 37225009 -
Genomics
SCARA5 in bone marrow stromal cell-derived exosomes inhibits colorectal cancer progression by inactivating the PI3K/Akt pathway. [Abstract]2023 Jul;115(4):110636. PMID: 37150230 -
IBRO Neurosci Rep
TNKS1 mediates the PTEN-PI3K/AKT pathway to regulate glycolysis and proliferation in gliomas. [Abstract]2026 Jan 21:20:186-195. PMID: 41660562 -
Discov Oncol
CDCA5 knockdown potentiates olaparib sensitivity in BRCA1-mutated ovarian cancer through autophagy activation. [Abstract]2025 Sep 30;16(1):1789. PMID: 41026320 -
Oral Dis
2024 Oct;30(7):4231-4242. PMID: 38225738 -
J Clin Lab Anal
Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K/AKT signaling pathway. [Abstract]2022 Dec;36(12):e24720. PMID: 36347827 -
Neurogastroenterol Motil
Acute stress induces visceral hypersensitivity via glucocorticoid receptor-mediated membrane insertion of TRPM8: Involvement of a non-receptor tyrosine kinase Pyk2. [Abstract]2020 Oct;32(10):1514-1528. PMID: 32391653 -
Int J Biochem Cell Biol
EFNA3-mediated autophagy suppression drives breast cancer proliferation, EMT and metastasis via PI3K/AKT/mTOR axis. [Abstract]2026 May:194:106928. PMID: 41763291 -
J Biochem Mol Toxicol
Silencing of PODXL2 Modulates Cell Viability and Tumor Immune Microenvironment of Prostate Cancer and Involves PI3K/AKT Pathway Inactivation. [Abstract]2025 Apr;39(4):e70210. PMID: 40152216 -
Genes (Basel)
SPAG9 Expression Predicts Good Prognosis in Patients with Clear-Cell Renal Cell Carcinoma: A Bioinformatics Analysis with Experimental Validation. [Abstract]2023 Apr 20;14(4):944. PMID: 37107702 -
Mol Biol Rep
Polyene phosphatidylcholine ameliorates synovial inflammation: involvement of PTEN elevation and glycolysis suppression. [Abstract]2023 Jan;50(1):687-696. PMID: 36370296 -
Technol Cancer Res Treat
LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma. [Abstract]2020 Jan-Dec:19:1533033820957023. PMID: 32910747 -
Onco Targets Ther
Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway. [Abstract]2019 Dec 4;12:10639-10650. PMID: 31824171 -
Immun Inflamm Dis
ADAMTS2 Modulates Inflammation, Autophagy, and Barrier Integrity Through PI3K/AKT/mTOR Signaling in LPS-Induced Acute Respiratory Distress Syndrome. [Abstract]2026 Apr;14(4):e70429. PMID: 42011035 -
Exp Eye Res
Licochalcone A alleviates laser-induced choroidal neovascularization by inhibiting the endothelial-mesenchymal transition via PI3K/AKT signaling pathway. [Abstract]2023 Jan:226:109335. PMID: 36436569 -
Toxicol In Vitro
Nickel nanoparticles affect the migration and invasion of HTR-8/SVneo cells by downregulating MMP2 through the PI3K/AKT pathway. [Abstract]2022 Apr;80:105328. PMID: 35150872 -
Curr Microbiol
Paeonol Inhibits the Replication of Bovine Herpesvirus Type 1 In Vitro Through Regulating the PI3K/AKT Pathway. [Abstract]2025 Feb 3;82(3):110. PMID: 39894854 -
PLoS One
Medioresinol from Eucommiae cortex improves myocardial infarction-induced heart failure through activation of the PI3K/AKT/mTOR pathway: A network analysis and experimental study. [Abstract]2024 Sep 27;19(9):e0311143. PMID: 39331625 -
PLoS One
MiR-27a inhibits the growth and metastasis of multiple myeloma through regulating Th17/Treg balance. [Abstract]2024 Oct 16;19(10):e0311419. PMID: 39413115 -
Theriogenology
RFRP-3 suppresses ovarian granulosa cell function in Tan sheep via dual signaling pathways: PI3K/AKT/mTOR and MAPK/ERK1/2. [Abstract]2026 Aug:260:117909. PMID: 41924772 -
-
J Steroid Biochem Mol Biol
Nano-curcumin attenuates tamoxifen resistance and malignant progression in ER-positive breast cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway. [Abstract]2025 Jul 3:254:106825. PMID: 40617262 -
Cell Biochem Biophys
Impairing Ferroptosis Through the PI3K/Akt/Nrf2 Pathway: The Way for Nerve Growth Factor to Mitigate Hypoxia-induced Cardiomyocyte Damage. [Abstract]2025 Jun;83(2):2023-2033. PMID: 39549229 -
Cell Biochem Biophys
Sirt4 Overexpression Modulates the JAK2/STAT3 and PI3K/AKT/mTOR Axes to Alleviate Sepsis-Induced Acute Lung Injury. [Abstract]2025 Jun;83(2):1785-1798. PMID: 39400781 -
World J Gastrointest Oncol
Deltonin enhances gastric carcinoma cell apoptosis and chemosensitivity to cisplatin via inhibiting PI3K/AKT/mTOR and MAPK signaling. [Abstract]2023 Oct 15;15(10):1739-1755. PMID: 37969408 -
Exp Ther Med
Ellagic acid inhibits high glucose-induced injury in rat mesangial cells via the PI3K/Akt/FOXO3a signaling pathway. [Abstract]2021 Sep;22(3):1017. PMID: 34373703 -
Biochem Biophys Res Commun
N6-methyladenosine methyltransferase METTL3 facilitates the aerobic glycolysis of non-small cell lung cancer cells by activating the PI3K/AKT/mTOR pathway. [Abstract]2025 Sep 8:778:152337. PMID: 40706246 -
Biochem Biophys Res Commun
Flavonoid derivative FB-15 inhibits the progression of nasopharyngeal carcinoma by targeting the PI3K-Akt signaling pathway. [Abstract]2025 May 16:771:152037. PMID: 40409114 -
Biochem Biophys Res Commun
TM6SF1 suppresses the progression of lung adenocarcinoma and M2 macrophage polarization by inactivating the PI3K/AKT/mtor pathway. [Abstract]2024 Jul 23:718:149983. PMID: 38718735 -
Oncol Lett
Hematoporphyrin derivative photodynamic therapy induces apoptosis and suppresses the migration of human esophageal squamous cell carcinoma cells by regulating the PI3K/AKT/mTOR signaling pathway. [Abstract]2023 Nov 15;27(1):17. PMID: 38034489 -
J Mol Histol
ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway. [Abstract]2023 Dec;54(6):621-631. PMID: 37776473 -
Biochem Biophys Res Commun
Gastrodin relieves cognitive impairment by regulating autophagy via PI3K/AKT signaling pathway in vascular dementia. [Abstract]2023 Sep 3:671:246-254. PMID: 37307708 -
Oncol Lett
Targeting transient receptor potential canonical 1 reduces non‑small cell lung cancer chemoresistance and stemness via inhibition of PI3K/AKT signaling. [Abstract]2023 Apr 13;25(6):224. PMID: 37153044 -
Korean J Physiol Pharmacol
Gaseous signal molecule SO2 regulates autophagy through PI3K/AKT pathway inhibits cardiomyocyte apoptosis and improves myocardial fibrosis in rats with type II diabetes. [Abstract]2022 Nov 1;26(6):541-556. PMID: 36302628 -
Biochem Biophys Res Commun
Chromogranin A-derived peptide CGA47-66 protects against septic brain injury by reducing blood-brain barrier damage through the PI3K/AKT pathway. [Abstract]2022 May 21;605:162-170. PMID: 35339012 -
Oncol Lett
MicroRNA-23b-3p targets non-SMC condensing I complex subunit G to promote proliferation and inhibit apoptosis of colorectal cancer cells via regulation of the PI3K/AKT signaling pathway. [Abstract]2021 Dec;22(6):812. PMID: 34671426 -
Mol Genet Genomics
WTAP-mediated m6A methylation of CEP55 promotes immune evasion in lung adenocarcinoma by activating the PI3K/AKT/mTOR pathway. [Abstract]2026 Jun 16;301(1):138. PMID: 42298019 -
Eur J Histochem
Aloe-emodin ameliorates chronic kidney disease fibrosis by inhibiting PI3K-mediated signaling pathway. [Abstract]2025 Jun 17;69(3). PMID: 40832995 -
Arch Dermatol Res
Imperatorin promotes melanin degradation in keratinocytes through facilitating autophagy via the PI3K/Akt signaling pathway. [Abstract]2024 Dec 5;317(1):70. PMID: 39636461 -
Int J Gen Med
Fire Acupuncture Combined with Pulse Radiofrequency Relieves Tactile Allodynia in Rats with Postherpetic Neuralgia. [Abstract]2025 Sep 19:18:5699-5716. PMID: 40994884 -
Curr Eye Res
Kisspeptin Suppresses the Growth of Primary Pterygial Cells via Inhibiting Chemokine (C-X-C Motif) Ligands in Microenvironment. [Abstract]2025 Jun 24:1-9. PMID: 40555256 -
Cancer Rep (Hoboken)
Quercetin Induces Apoptosis Through Downregulating P4HA2 and Inhibiting the PI3K/Akt/mTOR Axis in Hepatocellular Carcinoma Cells: An In Vitro Study. [Abstract]2025 May;8(5):e70220. PMID: 40347062 -
Clin Med Insights Oncol
MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway. [Abstract]2021 May 5:15:11795549211012666. PMID: 34017210 -
Cytotechnology
Nuclear receptor subfamily 2 group F member 2 transcriptionally activates 14-3-3 epsilon to promote diffuse large B-cell lymphoma progression. [Abstract]2026 Jun;78(3):96. PMID: 42040327 -
Cytotechnology
Proanthocyanidin B2 alleviates Pg. LPS-induced RAW264.7 cellular inflammation and oxidative stress via PI3K/Akt/NFkB pathway. [Abstract]2025 Apr;77(2):77. PMID: 40078375 -
In Vitro Cell Dev Biol Anim
Calycosin prevents IL-1β-induced articular chondrocyte damage in osteoarthritis through regulating the PI3K/AKT/FoxO1 pathway. [Abstract]2022 Jun;58(6):491-502. PMID: 35705795 -
-
Folia Neuropathol
MiR-182 ameliorates neuropathic pain by enhancing the transition from M1 to M2 phenotype polarization via PI3K/AKT signaling. [Abstract]2025;63(3):269-281. PMID: 41229245 -
Am J Transl Res
Cirsiliol suppresses malignant progression of hepatocellular carcinoma via regulation of glutamine metabolism. [Abstract]2025 Mar 15;17(3):2145-2153. PMID: 40226041 -
Ir J Med Sci
PLK4 inhibitor plus bortezomib exhibits a synergistic effect on treating multiple myeloma via inactivating PI3K/AKT signaling. [Abstract]2023 Apr;192(2):561-567. PMID: 35508865 -
Am J Transl Res
Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer. [Abstract]2021 Apr 15;13(4):2060-2076. PMID: 34017375 -
Respir Physiol Neurobiol
The Cosmc-mediated effects of neutrophil elastase on T antigen expression in BEAS-2B cells. [Abstract]2020 Oct;281:103496. PMID: 32683071 -
Curr Med Sci
PMEPA1-Mediated Treg Cell Impairment Promotes Endometrial Stromal Invasion via Excessive PI3K/AKT Signaling in Endometriosis. [Abstract]2025 Oct 16. PMID: 41100035 -
Curr Med Sci
Silencing NCAPD3 Inhibits Tumor Growth and Metastasis in Hepatocellular Carcinoma by Suppressing PI3K-AKT Signalling Pathway. [Abstract]2025 Apr;45(2):253-263. PMID: 40029498 -
Braz J Med Biol Res
Low-intensity pulsed ultrasound inhibits chondrocyte senescence by inhibiting PI3K/AKT/mTOR signaling. [Abstract]2025 Mar 24:58:e14408. PMID: 40136230 -
Braz J Med Biol Res
GSK3B inhibition reduced cervical cancer cell proliferation and migration by modulating the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition. [Abstract]2024 Aug 19:57:e13796. PMID: 39166606 -
-
bioRxiv
Efficient Generation of Functional TCRαβ+ Cytotoxic T Cells from hiPSCs via Small-Molecule Modulation. [Abstract]2026 Apr 1:2026.03.31.715684. PMID: 41959015 -
bioRxiv
Epigenome editing of human hematopoietic stem cells enables sustained and reversible thrombosis prevention. [Abstract]2026 Mar 29:2026.03.27.714536. PMID: 41928991 -
-
-
bioRxiv
2025 Mar 26:2025.03.24.645017. PMID: 40196615 -
-
-
-
-
bioRxiv
Endothelial Cell SMAD6 Balances ACVRL1/Alk1 Function to Regulate Adherens Junctions and Hepatic Vascular Development. [Abstract]2023 Mar 25:2023.03.23.534007. PMID: 36993438 -
Contrast Media Mol Imaging
Effects of circFOXO3 on the Proliferation and Invasion of Liver Cancer Cells by Regulating PI3K/Akt Pathway. [Abstract]2022 Jul 14:2022:2109908. PMID: 35909586 -
-
Dis Markers
Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway. [Abstract]2021 Sep 1:2021:9950663. PMID: 34512817 -
Oxid Med Cell Longev
Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis. [Abstract]2021 Mar 30:2021:6661534. PMID: 33859780
溶剤 & 溶解度
H2O : 4.8 mg/mL (1.47 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (283 KB)
-
SDS (254 KB)
- English - EN (254 KB)
- Français - FR (254 KB)
- Deutsch - DE (254 KB)
- Norwegian - NO (254 KB)
- Español - ES (254 KB)
- Swedish - SV (254 KB)
- Italian - IT (254 KB)
- Korean - KR (254 KB)
- Portuguese - PT (254 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Derossi D, et al. Stimulation of mitogenesis by a cell-permeable PI 3-kinase binding peptide. [Content Brief]
[2]. Xiaoli Feng, et al. Graphene Oxide Induces p62/SQSTM-dependent Apoptosis Through the Impairment of Autophagic Flux and Lysosomal Dysfunction in PC12 Cells. Acta Biomater. 2018 Nov;81:278-292. [Content Brief]
[3]. Zhiqing Sun, et al. GABAB Receptor-Mediated PI3K/Akt Signaling Pathway Alleviates Oxidative Stress and Neuronal Cell Injury in a Rat Model of Alzheimer's Disease. J Alzheimers Dis. 2020;76(4):1513-1526. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 0.3057 mL | 1.5287 mL | 3.0574 mL | 7.6436 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.